Literature DB >> 26341825

RORγt(+) IL-22-producing NKp46(+) cells protect from hepatic ischemia reperfusion injury in mice.

Elke Eggenhofer1, Manije Sabet-Rashedi2, Margareta Lantow2, Philipp Renner2, Jordi Rovira2, Gudrun E Koehl2, Hans J Schlitt2, Edward K Geissler2, Alexander Kroemer3.   

Abstract

BACKGROUND & AIMS: NKp46(+) cells are major effector cells in the pathogenesis of hepatic ischemia reperfusion injury (IRI). Nevertheless, the precise role of unconventional subsets like the IL-22-producing NKp46(+) cells (NK22) remains unknown. The purpose of this study was to examine the role of NK22 cells in IRI in transplantation, particularly with respect to regulation by the transcription factor ROR-gamma-t (RORγt).
METHODS: To explore the role of NK22 cells in IRI in the absence of adaptive immunity, B6.RORγt-(gfp/wt)-reporter and B6.RORγt-(gfp/gfp)-knockout (KO) mice on a Rag KO background underwent 90min partial warm ischemia, followed by 24h of reperfusion.
RESULTS: Rag KO mice that possess fully functional NKp46(+) cells, and Rag-common-γ-chain-double-KO (Rag-γc-DKO) mice that lack T, B and NKp46(+) cells, were used as controls. We found that Rag-γc-DKO mice lacking NK22 cells show more severe levels of hepatocellular damage (GPT, histological injury) when compared to both Rag-RORγt-reporter and Rag KO mice that possess NK22 cells. Importantly, Rag-RORγt-reporter and Rag KO mice undergoing IRI expressed high protein levels of both IL-22 and GFP (RORγt), suggesting a protective role for RORγt(+) NK22 cells in IRI. Therefore, we tested the hypothesis that RORγt critically protects from IRI through the induction of hepatic NK22 cells by studying Rag-Rorγt-DKO mice under IRI conditions. We found that the lack of RORγt(+) NK22 cells in Rag-Rorγt-DKO mice significantly enhanced IR-induced hepatocellular injury, a phenotype that could be reversed upon adoptive transfer of Rag-Rorγt-reporter NK22 cells into DKO mice.
CONCLUSIONS: RORγt(+) NK22 cells play an important protective role in IRI in mice.
Copyright © 2015 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  IL-22; Liver injury; Liver transplantation; NK cells; RORγt

Mesh:

Substances:

Year:  2015        PMID: 26341825     DOI: 10.1016/j.jhep.2015.08.023

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  11 in total

Review 1.  Heartbreakers or Healers? Innate Lymphoid Cells in Cardiovascular Disease and Obesity.

Authors:  Luke B Roberts; Graham M Lord; Jane K Howard
Journal:  Front Immunol       Date:  2022-05-11       Impact factor: 8.786

Review 2.  Interleukin-22 in alcoholic hepatitis and beyond.

Authors:  Xiaogang Xiang; Seonghwan Hwang; Dechun Feng; Vijay H Shah; Bin Gao
Journal:  Hepatol Int       Date:  2020-09-05       Impact factor: 6.047

3.  Remote ischemic perconditioning prevents liver transplantation-induced ischemia/reperfusion injury in rats: Role of ROS/RNS and eNOS.

Authors:  Ning He; Jun-Jun Jia; Jian-Hui Li; Yan-Fei Zhou; Bing-Yi Lin; Yi-Fan Peng; Jun-Jie Chen; Tian-Chi Chen; Rong-Liang Tong; Li Jiang; Hai-Yang Xie; Lin Zhou; Shu-Sen Zheng
Journal:  World J Gastroenterol       Date:  2017-02-07       Impact factor: 5.742

Review 4.  The Role of Innate Lymphoid Cells in Immune-Mediated Liver Diseases.

Authors:  Meifang Liu; Cai Zhang
Journal:  Front Immunol       Date:  2017-06-13       Impact factor: 7.561

5.  Mitofusin-2 mediated mitochondrial Ca2+ uptake 1/2 induced liver injury in rat remote ischemic perconditioning liver transplantation and alpha mouse liver-12 hypoxia cell line models.

Authors:  Ruo-Peng Liang; Jun-Jun Jia; Jian-Hui Li; Ning He; Yan-Fei Zhou; Li Jiang; Tao Bai; Hai-Yang Xie; Lin Zhou; Yu-Ling Sun
Journal:  World J Gastroenterol       Date:  2017-10-14       Impact factor: 5.742

6.  Liver-heart crosstalk controls IL-22 activity in cardiac protection after myocardial infarction.

Authors:  Ting-Ting Tang; Yuan-Yuan Li; Jing-Jing Li; Ke Wang; Yue Han; Wen-Yong Dong; Zheng-Feng Zhu; Ni Xia; Shao-Fang Nie; Min Zhang; Zhi-Peng Zeng; Bing-Jie Lv; Jiao Jiao; Heng Liu; Zong-Shu Xian; Xiang-Ping Yang; Yu Hu; Yu-Hua Liao; Qing Wang; Xin Tu; Ziad Mallat; Yu Huang; Guo-Ping Shi; Xiang Cheng
Journal:  Theranostics       Date:  2018-08-10       Impact factor: 11.556

7.  Enhanced Regeneration and Hepatoprotective Effects of Interleukin 22 Fusion Protein on a Predamaged Liver Undergoing Partial Hepatectomy.

Authors:  Heng Zhou; Guomin Xie; Yudi Mao; Ke Zhou; Ruixue Ren; Qihong Zhao; Hua Wang; Shi Yin
Journal:  J Immunol Res       Date:  2018-10-31       Impact factor: 4.818

Review 8.  Therapeutic manipulation of innate lymphoid cells.

Authors:  Laura M Cobb; Michael R Verneris
Journal:  JCI Insight       Date:  2021-03-22

Review 9.  Innate Lymphoid Cells and Myocardial Infarction.

Authors:  Wenling Yang; Jibin Lin; Jin Zhou; Yuqi Zheng; Shijiu Jiang; Shaolin He; Dazhu Li
Journal:  Front Immunol       Date:  2021-11-11       Impact factor: 7.561

Review 10.  Natural Killer Cells in Hepatic Ischemia-Reperfusion Injury.

Authors:  Miao Huang; Hao Cai; Bing Han; Yuhan Xia; Xiaoni Kong; Jinyang Gu
Journal:  Front Immunol       Date:  2022-03-28       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.